AWARD
A -- Advanced Development through Licensure of a Hemorrhagic Fever Virus Therapeutic
- Notice Date
- 7/16/2010
- Notice Type
- Award Notice
- NAICS
- 541711
— Research and Development in Biotechnology
- Contracting Office
- US Army Space and Missile Defense Command, Deputy Commander, ATTN SMDC-CM-AP, P.O. Box 1500, Huntsville, AL 35807-3801
- ZIP Code
- 35807-3801
- Solicitation Number
- W9113M-09-R-0008
- Archive Date
- 8/15/2010
- Point of Contact
- Sandra OConnell, 301-619-2895
- E-Mail Address
-
US Army Space and Missile Defense Command, Deputy Commander
(sandra.oconnell@us.army.mil)
- Small Business Set-Aside
- N/A
- Award Number
- W9113M-C-0056
- Award Date
- 7/14/2010
- Awardee
- AVI Biopharma, Inc.<BR>4575 SW Research Way Suite 200<BR>Corvallis, OR 97333
- Award Amount
- $80,396,827.37
- Line Number
- 0001, 0005
- Description
- This contract action was not awarded as a fixed price type because uncertainties involved in contract performance did not permit costs to be estimated with sufficient accuracy to use any type of fixed price contract. As such, a cost-reimbursement type action was awarded (FAR 16.301-2). Advanced Development through Licensure of Hemorrhagic Fever Virus Therapeutics, Ebola and Marburg
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/USA/SMDC/DASG60/Awards/W9113M-C-0056.html)
- Record
- SN02209238-W 20100718/100716235525-4e20a80e1ac5e3dbf1be0d9fdae700b0 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |